Clinical Trial Update: Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated a three-drug regimen (fludarabine, cytarabine, and topotecan) in patients with relapsed or refractory acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)
• Topotecan (topotecan)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Myeloid Leukemia | Phase 4 | Status: COMPLETED